TNF Pharmaceuticals Inc. recently released its audited consolidated financial statements for the years ending December 31, 2023, and 2024.
The report includes comprehensive information on the company's financial position, operations, and cash flows.
The auditors provided an opinion on the fairness of the financial statements and highlighted critical audit matters.
Fair Financial Presentation
The auditors confirmed that the financial statements present fairly the financial position of TNF Pharmaceuticals Inc.
Going Concern Status
Concerns were raised regarding the company's ability to continue as a going concern due to net losses and negative cash flows.
Responsibility and Independence
The responsibility for the financial statements lies with the company's management, while the audit was conducted by an independent public accounting firm.
- The report's mention of substantial doubt about TNF Pharmaceuticals Inc.'s ability to continue as a going concern may impact investor confidence.
- Disclosure of critical audit matters enhances transparency in financial reporting and signals a proactive approach to addressing challenges.
TNF Pharmaceuticals Inc. faces challenges in maintaining operations as a going concern, yet the transparency in the financial statement reporting reflects a commitment to disclosure and accountability.